Revista española de salud pública
-
Rev. Esp. Salud Publica · Nov 2005
Comparative Study[Use of acetylcholinesterase inhibitors and memantine in Alzheimer-type dementia].
The therapeutic options to treat Alzheimer-type dementia (ATD) in recent years, have made it increasingly necessary to become familiar with the employment pattern of these new medicinal products. ⋯ The use of memantine (in monotherapy or in combination) is more frequent in patients under 64 years old. Female sex was found to be a factor associated with presenting ATD to pharmacological treatment.